Evercore ISI Group Reiterates Outperform Rating on Repligen Corporation (RGEN)

Market Context

Repligen Corporation operates in the Healthcare sector. The stock currently trades at $141.46 with a market capitalization of $9.1B. The stock has gained 9.7% over the past 52 weeks.

Analyst coverage from Evercore ISI Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Repligen Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Repligen Corporation

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 06, 2026	Evercore ISI Group	Outperform	N/A
Jun 03, 2026	HSBC	Buy	N/A
May 15, 2026	RBC Capital	Outperform	N/A
May 06, 2026	JP Morgan	Overweight	N/A
May 06, 2026	Barclays	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View RGEN Stock Page